HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

immunotoxin 4D5MOCB-ETA

the immunotoxin 4D5MOCB-ETA was developed by genetically fusing a truncated form of Pseudomonas aeruginosa exotoxin A (ETA) (ETA(252-608)KDEL) to the highly stable humanized single-chain antibody fragment (scFv) 4D5MOCB; has potent and selective antitumor activity
Also Known As:
4D5MOCB-ETA
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Di Paolo, Claudio: 1 article (07/2003)
2. Plückthun, Andreas: 1 article (07/2003)
3. Zangemeister-Wittke, Uwe: 1 article (07/2003)
4. Willuda, Jörg: 1 article (07/2003)
5. Lauffer, Ikar: 1 article (07/2003)
6. Tschudi, Dominique: 1 article (07/2003)
7. Stahel, Rolf A: 1 article (07/2003)
8. Waibel, Robert: 1 article (07/2003)
9. Kubetzko, Susanne: 1 article (07/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Squamous Cell Carcinoma (Epidermoid Carcinoma)
3. Carcinoma (Carcinomatosis)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)